QA: AbbVie Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2021_AbbVie_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001551152, AbbVie Inc.

  xvar xval
0 AssetsCurrent 24,173,000,000
1 IntangibleAssetsNetIncludingGoodwill 116,000,000,000
2 PropertyPlantAndEquipmentNet 5,248,000,000
3 remainder_Assets 5,144,000,000
4 LiabilitiesCurrent 28,661,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 15,387,000,000
8 SellingGeneralAndAdministrativeExpense 11,299,000,000
9 ResearchAndDevelopmentExpense 7,755,000,000
10 remainder_Expenses -1,224,000,000
11 remainder_Revenues 45,804,000,000
12 remainder_NetIncome -7,965,000,000
13 remainder_ComprehensiveNetIncome 473,000,000
  yvar yval
0 Assets 150,565,000,000
1 Liabilities 28,661,000,000
2 Expenses 33,217,000,000
3 Revenues 45,804,000,000
4 StockholdersEquity 121,904,000,000
5 NetIncome 4,622,000,000
6 ComprehensiveNetIncome 4,858,500,000
7 BaseVar 133,342,500,000
8 EconomicCapitalRatio 2.39

Edgar->Model Mapping

Feature Distribution

Change over Time